STAAR Surgical Company
STAA
$18.03
$0.150.84%
NASDAQ
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Net Income | -541.31% | 107.18% | 21.69% | -223.21% | 14.68% |
| Total Depreciation and Amortization | 95.96% | 30.83% | 5.04% | 10.45% | -12.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 171.32% | 6.36% | -9.76% | 29.80% | -12.35% |
| Change in Net Operating Assets | 25.07% | 16.42% | -17.48% | 217.74% | 352.90% |
| Cash from Operations | -97.99% | 163.87% | -65.13% | 525.60% | 976.40% |
| Capital Expenditure | -85.40% | 32.16% | -106.90% | -79.32% | 23.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -154.02% | -170.71% | -209.45% | 66.66% | 159.71% |
| Cash from Investing | -187.02% | -210.68% | -303.19% | 62.96% | 147.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.50% | -7.69% | -5.00% | 4.76% | 2.44% |
| Issuance of Common Stock | -90.20% | -77.17% | -74.81% | 904.72% | 67.90% |
| Repurchase of Common Stock | -10,800.00% | 100.00% | -23.70% | 33.53% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -129.97% | -77.28% | -87.48% | 398.02% | 81.68% |
| Foreign Exchange rate Adjustments | -201.50% | 541.28% | 25.17% | -9,470.00% | 10.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.69% | -187.89% | -761.05% | 1,075.06% | 230.04% |